B · Normal
[Hanyu Pharmaceutical: Wholly-owned subsidiary Carboprost Trometamol Injection has received a drug registration certificate] On September 7, Hanyu Pharmaceutical (300199.SZ) announced that the company's wholly-owned subsidiary Gansu Chengji Biopharmaceutical Co., Ltd. recently received the "Drug Registration Certificate" for Carboprost Trometamol Injection issued by the National Medical Products Administration. This drug is a prostaglandin drug, mainly used to treat postpartum hemorrhage caused by uterine atony. Approval for marketing is deemed to have passed the quality and efficacy consistency evaluation of generic drugs.
Comments